Abstract:Capture of endothelial progenitor cells (EPCs) in situ has been considered as a promising strategy for the rapid endothelialization and long-term patency of artificial blood vessels and implant devices. In this study, a CD133+ EPC capture surface was fabricated by grafting CD133 antibody (a more specific EPC surface marker than CD34) and Arg-Glu-Asp-Val (REDV) peptideon the methacrylate-grafted hyaluronic acid (MA-HA) and heparin-hybridized (MA-HA&Heparin) resisting layer. Vascular endothelial growth factor (VEGF) was further conjugated to the immobilized heparin. This engineered surface showed good hemocompatibility and significantly higher ability of capturing CD133+ EPCs from human peripheral blood mononuclear cells (PBMCs) and obviously upregulated the expression of endothelial cell (EC) marker genes of EPCs such as VEGF receptor 2 (VEGFR2), CD31, VE-cadherin, and von Willebrand factor (vWF), facilitating the differentiation of EPCs into ECs. The dramatically enhanced EPC proliferation on this surface was dependent on the integrin-VEGFR synergistic signaling, as ERK1/2 phosphorylation was only significantly enhanced on the REDV and VEGF co-immobilized surface. This study highlights a new surface coating strategy for blood-contact materials based on the specific EPC capturing and rapid endothelialization. STATEMENT OF SIGNIFICANCE: Capture of endothelial progenitor cells (EPCs) in situ is a promising strategy for the rapid endothelialization and long-term patency of artificial blood vessels and scaffolds. More specific capture of EPCs by targeting CD133 rather than CD34 can better reduce the risk of inflammation and restenosis. On the other hand, an appropriate microenvironment for EPC proliferation is equally important for endothelialization, which is rarely considered by the existing EPC capture strategies. In this study, the capture ratio of EPCs was significantly increased by simultaneously grafting CD133 antibody and VEGF on a MA-HA and heparin-hybridized antifouling layer. Further, proliferation of EPCs after capture was significantly promoted by grafting VEGF and REDV peptide through the integrin-VEGFR synergistic signaling. This study highlights a new strategy for the surface coating of blood-contact materials based on specific EPC capture and rapid endothelialization.

[Immobilization of CD34 Antibodies Onto Ethylene-Vinyl Acetate Copolymer Coatings and in Vitro Cell Attachments].

Immobilization of CD34 Antibodies onto 316L Stainless Steel and in vitro Cytocompatibility

Combinatorial coating of adhesive polypeptide and anti-CD34 antibody for improved endothelial cell adhesion and proliferation

Site-directed Immobilization of Antibodies Onto Blood Contacting Grafts for Enhanced Endothelial Cell Adhesion and Proliferation

Bioinspired, Artificial, Small-Diameter Vascular Grafts with Selective and Rapid Endothelialization Based on an Amniotic Membrane-Derived Hydrogel.

Plasma-Mediated Immobilization of Antibody with PEG As Spacer for Enhanced Endothelial Cell Adhesion and Proliferation

Development of Mussel Adhesive Polypeptide Mimics Coating for In-Situ Inducing Re-Endothelialization of Intravascular Stent Devices

Immobilization of serum albumin and peptide aptamer for EPC on polydopamine coated titanium surface for enhanced in-situ self-endothelialization.

Anti-Cd34 Antibody Functionalized Swollen Polymeric Coating for Endothelial Cell Rapid Selectively Capture

Direct Adsorption of Anti-CD34 Antibodies on the Nano-Porous Stent Surface to Enhance Endothelialization.

Selective endothelial cells adhesion to Arg-Glu-Asp-Val peptide functionalized polysaccharide multilayer

Preparation of Vascular Endothelial Cadherin Loaded-Amphoteric Copolymer Decorated Coronary Stents for Anticoagulation and Endothelialization

In Situ Endothelialization of Intravascular Stents Coated with an Anti-Cd34 Antibody Functionalized Heparin-Collagen Multilayer

Co-immobilization of CD133 Antibodies, Vascular Endothelial Growth Factors, and REDV Peptide Promotes Capture, Proliferation, and Differentiation of Endothelial Progenitor Cells.

Development of a universal, oriented antibody immobilization method to functionalize vascular prostheses for enhanced endothelialization for potential clinical application

Covalent Immobilization of Biomolecules on Stent Materials Through Mussel Adhesive Protein Coating to Form Biofunctional Films.

Distinctive Effects of CD34- and CD133-specific Antibody-Coated Stents on Re-Endothelialization and In-Stent Restenosis at the Early Phase of Vascular Injury

Endothelialization and In-Stent Restenosis on the Surface of Glycoprotein Iiia Monoclonal Antibody Eluting Stent

Ulvan mediated VE cadherin antibody and REDV peptide co-modification to improve endothelialization potential of bioprosthetic heart valves

Zwitterionic polycarboxybetaine coating functionalized with REDV peptide to improve selectivity for endothelial cells.

A Zwitterionic Hydrogel Coated Titanium Surface with High-Efficiency Endothelial Cell Selectivity for Rapid Re-Endothelialization.